您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > Wedelolactone
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Wedelolactone
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Wedelolactone图片
CAS NO:524-12-9
包装与价格:
包装价格(元)
10 mM * 1 mL in DMSO电议
5mg电议
10mg电议
20mg电议
50mg电议
100mg电议

产品名称
蟛蜞菊内酯
产品介绍
Wedelolactone 通过直接抑制 IKK 复合物抑制 lps 诱导的caspase-11表达。Wedelolactone 抑制5-Lox,其IC50值为 2.5 μM。Wedelolactone 通过下调 PKCε 诱导的 caspase 依赖的前列腺癌细胞凋亡,而不抑制 Akt。Wedelolactone 可从鳢肠中提取,可用于癌症的研究。
生物活性

Wedelolactone suppresses LPS-inducedcaspase-11expression by directly inhibits theIKKComplex. Wedelolactone also inhibits5-lipoxygenase(5-Lox) with anIC50of 2.5 μM. Wedelolactone induces caspase-dependentapoptosisin prostatecancercells via downregulation ofPKCεwithout inhibitingAkt. Wedelolactone can extract from Eclipta alba, and it can be used for the research ofcancer[1][2][3].

IC50& Target[1][2][3]

Caspase-11

 

5-LOX

2.5 μM (IC50)

Apoptosis

 

体外研究
(In Vitro)

Wedelolactone (0-5 μg/mL; 0-21 d) enhances bone marrow mesenchymal stem cells (BMSC) differentiation towards osteoblasts[3].
Wedelolactone (0-6 μg/mL; 0-9 d) inhibits GSK3β activity and increases β-catenin and runx2 nuclear accumulation in BMSC, and inhibits the effect of RANKL[3].
Wedelolactone (0-5 μg/ml; 60 min) inhibits GSK3β activity and proves GSK3β is the target of wedelolactone[3].
Wedelolactone (0-5 μg/ml; 6 d) inhibits c-src, c-fos and cathepsin k expression level[3].

Cell Differentiation Assay[3]

Cell Line:Mouse BMSC
Concentration:0-5 μg/mL
Incubation Time:0, 6, 9, 12 and 21 days
Result:Increased Mouse BMSC into osteoblastic cells and dose-dependently increased the activity of alkaline phosphatase at incubation for 9 days.

Western Blot Analysis[3]

Cell Line:Mouse BMSC and RAW264.7 cells
Concentration:0-5 μg/mL
Incubation Time:0-9 days
Result:Decreased GSK3β expression level and up-regulated GSK3β phosphorylation, nuclear accumulation of β-catenin and runx2 in BMSC. Inhibited RANKL-induced phosphorylation of NF-κB/p65 and the expression level of c-fos and c-Src.

Cell Viability Assay[3]

Cell Line:Mouse BMSC
Concentration:0.1, 1.25, 2.5, 5 μg/ml
Incubation Time:60 min
Result:Inhibited GSK3β activity with an IC50of 21.7 μM weeker than staurosporin which is a GSK3β inhibitor and proved GSK3β is a target.

RT-PCR[3]

Cell Line:RAW264.7 cells
Concentration:0, 0.6, 1.25, 2.5 and 5 μg/mL
Incubation Time:6 days
Result:Inhibited the expression of osteoclast differentiation related marker genes c-src, c-fos and cathepsin in RAW264.7 cells.
体内研究
(In Vivo)

Wedelolactone (10 mg/kg; i.p. every 2 days for 4 weeks) decreases bone volumn and trabecular number at the femur after ovarietomy, and prevents the VOX-induced bone loss[3].

Animal Model:Ovariectomized 9-week-old mice[3]
Dosage:10 mg/kg
Administration:Intraperitoneal injection; 10 mg/kg every 2 days; for 4 weeks
Result:Inhibited osteoclast activity and stimulated osteoblast differentiation to achieved osteoprotective effect.
分子量

314.25

性状

Solid

Formula

C16H10O7

CAS 号

524-12-9

中文名称

蟛蜞菊内酯;蟛蜞内酯;蟛蜞菊内脂

结构分类
  • Phenols
  • Polyphenols
来源
  • Plants
  • Compositae
  • Eclipta prostrata(Linn.) Linn.
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Powder-20°C3 years
In solvent-80°C6 months
-20°C1 month
溶解性数据
In Vitro: 

DMSO : 125 mg/mL(397.77 mM;Need ultrasonic)

配制储备液
浓度溶剂体积质量1 mg5 mg10 mg
1 mM3.1822 mL15.9109 mL31.8218 mL
5 mM0.6364 mL3.1822 mL6.3644 mL
10 mM0.3182 mL1.5911 mL3.1822 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80℃, 6 months; -20℃, 1 month。-80℃ 储存时,请在 6 个月内使用,-20℃ 储存时,请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂: 10% DMSO    40%PEG300   5%Tween-80   45% saline

    Solubility: ≥ 2.08 mg/mL (6.62 mM); Clear solution

    此方案可获得 ≥ 2.08 mg/mL (6.62 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;向上述体系中加入50 μL Tween-80,混合均匀;然后继续加入 450 μL生理盐水定容至 1 mL。

    将 0.9 g 氯化钠,完全溶解于 100 mL ddH2O 中,得到澄清透明的生理盐水溶液
  • 2.

    请依序添加每种溶剂: 10% DMSO    90%corn oil

    Solubility: ≥ 2.08 mg/mL (6.62 mM); Clear solution

    此方案可获得 ≥ 2.08 mg/mL (6.62 mM,饱和度未知) 的澄清溶液,此方案不适用于实验周期在半个月以上的实验。

    以 1 mL 工作液为例,取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中,混合均匀。

*以上所有助溶剂都可在本网站选购。